Provenienza dei contatti di primo grado di Sarah Khan
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Sarah Khan tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
IBM | Packaged Software | Corporate Officer/Principal | |
LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Executive Officer | |
Apax Partners, Inc.
Apax Partners, Inc. Investment ManagersFinance Founded in 1976, Apax Partners, Inc. is a venture capital/private equity firm located in New York City. The firm is a subsidiary of London-based Apax Partners LLP | Investment Managers | Corporate Officer/Principal | |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
AcuFocus, Inc.
AcuFocus, Inc. Medical SpecialtiesHealth Technology AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member | |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Paul Capital Partners LP
Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Investment Managers | Private Equity Investor | |
United States Naval Academy | College/University | Undergraduate Degree | |
University of Maryland | College/University | Graduate Degree | |
Helomics Corp.
Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | Medical/Nursing Services | Chairman | |
Invus Public Equities Advisors LLC
Invus Public Equities Advisors LLC Investment ManagersFinance Invus Public Equities Advisors LLC is an investment advisory firm headquartered in New York City. The firm was founded by Raymond Debbane in 1985 and is a subsidiary of The Invus Group LLC. Invus Public Equities Advisors serves as the general partner of Invus Public Equities, L.P. | Investment Managers | Portfolio Manager-Equities | |
Politehnica University of Bucharest | College/University | Undergraduate Degree | |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Investment Managers | Founder | |
Suneva Medical, Inc.
Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Suneva Medical, Inc. develops, manufactures and commercializes novel, differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets. It offers ArteFill, ReFissa, Bellafill, and ReGenica Skincare products. The company is headquartered in San Diego, CA. | Electronic Equipment/Instruments | Chairman | |
Harvard Business School Health Industry Alumni Association | Director/Board Member | ||
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA. | Biotechnology | Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Harvard Business School | College/University | Masters Business Admin | |
Exigo Capital Corp.
Exigo Capital Corp. Finance/Rental/LeasingFinance Exigo Capital Corp. provides financial services. The private company is based in New York, NY. The company was founded by Krister Nilsson. | Finance/Rental/Leasing | Corporate Officer/Principal | |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | Biotechnology | Director/Board Member | |
Royaltyrx Capital LLC
Royaltyrx Capital LLC Financial ConglomeratesFinance Royaltyrx Capital LLC provides investment services in the pharmaceutical industry. The American company was founded by Todd C. Davis. | Financial Conglomerates | Founder | |
Benuvia Therapeutics, Inc.
Benuvia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Benuvia Therapeutics, Inc. engages in pharmaceutical and therapeutic drug development services. The company is headquartered in Chandler, AZ. | Pharmaceuticals: Major | Chief Executive Officer | |
Fly for MS | Founder | ||
Virocell Biologics Ltd.
Virocell Biologics Ltd. BiotechnologyHealth Technology Virocell Biologics Ltd. is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials. The company is based in London, UK. The British company leverages its expertise in vector manufacture directly into the production of gene-modified cells, both adherent cells such as Mesenchymal Stromal/Stem cells and suspension cultures such as CAR T-cells. Virocell Biologics is committed to leveraging its deep experience to rapidly design and select a manufacturing strategy best suited to the client's objectives. The company was founded by Farzin Farzaneh, John W. Hadden. John W. Hadden has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
CHROMOCELL THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Chairman |
Statistiche
Distribuzione geografica
Stati Uniti | 28 |
Romania | 2 |
Regno Unito | 2 |
Settori
Health Technology | 12 |
Finance | 9 |
Consumer Services | 6 |
Technology Services | 2 |
Health Services | 2 |
Posizioni
Director/Board Member | 12 |
Corporate Officer/Principal | 7 |
Chairman | 5 |
Independent Dir/Board Member | 5 |
Chief Executive Officer | 3 |
Contatti più connessi
Insiders | |
---|---|
Todd Davis | 23 |
Andrei Floroiu | 8 |
- Borsa valori
- Insiders
- Sarah Khan
- Connessioni Società